Analysis of the GSE117872 dataset (n = 400) revealed that compared with the cisplatin-sensitive group (n = 240), higher TRPM7 expression was found in the cisplatin-resistant HNSCC group (n = 160) (1.32-fold, p < 0.001) (Figure 4A). The gene discussed is TRPM7; the disease is head and neck squamous cell carcinoma.